Skip to main content

Table 3 Prevalence of metabolic syndrome and metabolic score among Ghanaian pre-and postmenopausal women

From: The prevalence of metabolic syndrome and its predominant components among pre-and postmenopausal Ghanaian women

Parameters Total Postmenopausal Premenopausal P value
(n = 250) (n = 107) (n = 143)
Prevalence of metabolic syndrome
WHO 36(14.4%) 27(25.2%) 9(6.3%) <0.0001
NCEP-ATP III 65(26.0%) 44(41.1%) 21(14.7%) <0.0001
IDF 73(29.2%) 46(43.0%) 27(18.9%) <0.0001
H_MS 76(30.4%) 47(43.9%) 29(20.3%) <0.0001
Prevalence of clustering of one or two or more components of metabolic syndrome
WHO
0 34(13.6%) 1(1.0%) 33(23.1%) <0.0001
1 70(28.0%) 20(18.7%) 50(35.0%) 0.0050
2 76(30.4%) 45(42.1%) 31(21.7%) 0.0010
>2 without MetS 34(13.6%) 14(13.1%) 20(14.0%) 1.0000
NCEP-ATP III
0 30(12.0%) 3(2.8%) 27(18.9%) <0.0001
1 57(22.8%) 13(12.1%) 44(30.8%) 0.0010
2 98(39.2) 47(43.9%) 51(35.7%) 0.1930
IDF
0 13(5.2%) 0(0.0%) 13(9.1%) 0.0010
1 50(20.0%) 8(7.5%) 42(29.4%) <0.0001
2 111(44.4%) 52(48.6%) 59(41.3%) 0.3030
>2 without MetS 3(1.2%) 1(1.0%) 2(1.4%) 1.0000
H_MS
0 13(5.2%) 0(0.0%) 13(9.1%) 0.0010
1 50(20.0%) 8(7.5%) 42(29.4%) <0.0001
2 111(44.4%) 52(48.6%) 59(41.3%) 0.3030
  1. Data are presented as a proportion with corresponding percentages in parenthesis. The proportions were compared using Fischer’s exact test. Mets: Metabolic Syndrome. WHO: World Health Organization, NCEP-ATP III: National Cholesterol Education Program-Adult Treatment Panel III, IDF: International Diabetes Federation and H_MS: Harmonization.